web analytics
Pubblicità

di Giancarlo Nicoli

Thursday, 14 June 2012
Four Later-Stage Immunotherapy Strategies Appear Promising
http://www.onclive.com/publications/Oncology-live/2012/May-2012/Four-Later-Stage-Immunotherapy-Strategies-Appear-Promising

Wednesday, 13 June 2012
Dendreon Shareholders Vent at Annual Meeting
http://www.xconomy.com/seattle/2012/06/13/dendreon-shareholders-vent-at-annual-meeting/

Wednesday, 13 June 2012
Dendreon shareholders complain about stock losses
http://seattletimes.nwsource.com/html/businesstechnology/2018421846_dendreon14.html

Wednesday, 13 June 2012
Summer Street starts Dendreon with buy
http://www.investorvillage.com/smbd.asp?mb=971&mn=440451&pt=msg&mid=11818750

Tuesday, 12 June 2012
Provenge vs Zytiga for Prostate Cancer: What You Should Know
http://www.prostate.net/2012/prostate-cancer/provenge-vs-zytiga-what-you-should-know/

Tuesday, 12 June 2012
Zytiga plus Provenge could become SOC in chemo-naïve metastatic prostate cancer
http://www.biocentury.com/biotech-pharma-news/coverstory/2012-06-11/
zytiga-plus-provenge-could-become-soc-in-chemo-nave-metastatic-prostate-cancer-a1

Monday, 11 June 2012
Miller on the Burrill Report (June 11, 2012): Why Dendreon May Have Felt Less Pain at ASCO than Expected (.MP3,16.21 Mb) (It’s an audio podcast)
http://www.burrillreport.com/content/podcast/CUT_SPM_BRP-6-11-12.mp3

Monday, 11 June 2012
Provider update from yahoo
http://www.investorvillage.com/smbd.asp?mb=971&mn=440240&pt=msg&mid=11809917

 

@ @ @

DNDN website:
http://www.dendreon.com/

Provenge website:
http://provenge.com/

All links are verified and working at date of publication.

Tags:

, , , ,

Comments

Leave a Reply

You must be logged in to post a comment.